Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs

Mutagenesis

Volumn 27, Issue 4, 2012, Pages 387-413

  Brambilla, Giovanni ^a   Mattioli, Francesca ^a   Robbiano, Luigi ^a   Martelli, Antonietta ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ACICLOVIR; AMPICILLIN; AMPRENAVIR; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTIVIRUS AGENT; AZITHROMYCIN; CHLORAMPHENICOL; CLOFAZIMINE; CYCLOSERINE; DAPSONE; DELAVIRDINE; ENTECAVIR; ETHIONAMIDE; GRISEOFULVIN; INDINAVIR; ISONIAZID; LAMIVUDINE; METRONIDAZOLE; NEVIRAPINE; NITROFURANTOIN; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE; TERBINAFINE; UNINDEXED DRUG; ZALCITABINE; ZIDOVUDINE;

APLASTIC ANEMIA; BLADDER CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CARCINOGENESIS; CARCINOGENICITY; CHROMOSOME ABERRATION; DISEASE ASSOCIATION; FOLLOW UP; GENOTOXICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHOMA; MOUTH CANCER; NONHUMAN; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRENATAL EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN CANCER; THYROID CANCER; TOXICITY TESTING; UTERINE CERVIX CANCER;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIMALARIALS; ANTIVIRAL AGENTS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; HUMANS; MUTAGENS;

ANIMALIA;

EID: 84863536272     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger094     Document Type: Review

References (77)

1. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). (1996) Guideline for Industry. S2A. Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals.
2. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). (1997). Guidance for Industry. S2B. Genotoxicity: A Standard Battery for Genotoxicity Testing of Pharmaceuticals.
3. Müller, L., Kikuchi, Y., Probst, G., Schechtman, L., Shimada, H., Sofuni, T. and Tweats, D. (1999) ICH-harmonized guidance on genotoxicity testing of pharmaceuticals; evolution, reasoning and impact. Mutat. Res., 436, 195-225. (Pubitemid 29246090)
4. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). (1996) Guidelines for Industry. S1A. The Need for Long-term Rodent Carcinogenicity Studies of Pharmaceuticals.
5. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). (1997) Guidance for Industry. S1B. Testing for Carcinogenicity of Pharmaceuticals.
6. Sweetman, S.C. (ed.). (2007) Martindale. The Complete Drug Reference. 35th edn. Pharmaceutical Press, London.
7. Snyder, R. D. and Green, J. W. (2001) A review of the genotoxicity of marketed pharmaceuticals. Mutat. Res., 488, 151-169. (Pubitemid 32436429)
8. International Agency for Research on Cancer. 1972-2010. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 1-99, IARC, Lyon, France.
9. US Department of Health and Human Services. (1987) Registry of Toxic Effects of Chemical Substances, 1985-1988 ed. Washington, DC.
10. (2005) Physicians' Desk Reference. 59th edn. Thomson PDR, Montvale, NJ.
11. U.S. National Library of Medicine-Toxnet, Toxicology Data Network. http://www.toxnet.nlm.nih.gov.
12. International Agency for Research on Cancer. (2000) Some antiviral and antineoplastic drugs, and other pharmaceutical agents. IARC Monogr. Eval. Carcinog. Risks Hum., 76, 47-71.
13. Tomicic, M. T., Bey, E., Wutzler, P., Thust, R. and Kaina, B. (2002) Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovir. Mutat. Res., 505, 1-11.
14. Ishidate, M. Jr., Harnois, M. C. and Sofuni, T. (1988) A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutat. Res., 195, 151-213. (Pubitemid 18066068)
15. International Agency for Research on Cancer. (1990). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 50. Pharmaceutical Drugs, IARC, Lyon, France.
16. Amacher, D. E., Ellis, J. H. Jr., Joice, A. J., Muehlbauer, P. A., Turner, G. N., Wahrenburg, M. G., Holden, H. E. and Ray, V. A. (1993) Preclinical toxicology studies with azithromycin: genetic toxicology evaluation. Mutat. Res., 300, 79-90. (Pubitemid 23181724)
17. Thomas, S. M., Silburn, K. A. and MacPhee, D. G. (1987) Frameshift mutagenesis by chloroquine in Escherichia coli and Salmonella typhimurium. Mutat. Res., 192, 233-237. (Pubitemid 18002291)
18. Espinosa-Aguirre, J. J., Ramirez Santos, J. and Cortinas de Nava, C. (1989) Influence of the UVR-repair system on the mutagenicity of antiparasitic drugs. Mutat. Res., 222, 161-166.
19. Shubber, E. K., Jacobson-Kram, D. and Williams, J. R. (198) Comparison of the Ames assay and the induction of sister chromatid exchanges: results with ten pharmaceuticals and five selected agents. Cell Biol. Toxicol., 2, 379-399.
20. Kadotani, S., Arisawa, M. and Maruyama, H. B. (1984) Mutagenicity examination of several non-steroidal anti-inflammatory drugs in bacterial systems. Mutat. Res., 138, 133-136. (Pubitemid 15178009)
21. O'Donovan, M. R. (1990) The comparative responses of Salmonella typhimurium TA1537 and TA97A to a range of reference mutagens and novel compounds. Mutagenesis, 5, 267-274.
22. Sideropoulos, A. S. and Specht, S. M. (1984) Evaluation of microbial testing methods for the mutagenicity of quinoline and its derivatives. Curr. Microbiol., 11, 59-65.
23. Chatterjee, T., Mukopadhyay, A., Khan, K. A. and Giri, K. (1998) Comparative mutagenic and genotoxic effects of three antimalarial drugs, chloroquine, primaquine and amodiaquine. Mutagenesis, 13, 619-624. (Pubitemid 28523826)
24. FDA, Center for Drug Evaluation and Research. http://www.FDA.gov.cder.
25. Tanaka, K., Ino, T., Sawahata, T., Marui, S., Igaki, H. and Yashima, H. (1985) Mutagenicity of N-acetyl and N, N′-diacetyl derivatives of 3 aromatic amines used as epoxy-resin hardeners. Mutat. Res., 143, 11-15. (Pubitemid 15005780)
26. Takahashi, A. and Ono, H. (1993) Mutagenicity assessment in 44 epoxy resin hardeners in Salmonella typhimurium tester strains. Chem. Exp., 8, 785-788.
27. IARC. (1980) Some pharmaceutical drugs. IARC Monogr. Eval. Carcinog. Risk Hum., 24, 59-76.
28. Dunkel, V. C., Zeiger, E., Brusick, D., McCoy, E., McGregor, D., Mortelmans, K., Rosenkranz, H. S. and Simmon, V. F. (1985) Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella thyphimurium and Escherichia coli. Environ. Mol. Mutagen., 7 (Suppl. 5), 1-248.
29. NCI/NTP. (1977) Carcinogenesis Technical Report Series; National Cancer Institute/National Toxicology Program; U.S. Department of Health and Human Services, TR-20.
30. Goodman, D. G., Ward, J. M. and Reichardt, W. D. (1984) Splenic fibrosis and sarcomas in F344 rats fed diets containing aniline hydrochloride, p-chloroaniline, azobenzene, o-toluidine hydrochloride, 4,4′- sulfonyldianiline, or D & C red No. 9. J. Natl Cancer Inst., 73, 265-273. (Pubitemid 14090855)
31. Shaheen, S. and Rao, M. S. (1990) Evaluation of mutagenicity of ethambutol hydrochloride using Ames test. Trends Life Sci., 5, 7-9.
32. Mavournin, K. H., Blakey, D. H., Cimino, M. C., Salamone, M. F. and Heddle, J. H. (1990) The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 239, 29-80.
33. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T. and Mortelmans, K. (1988) Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ. Mol. Mutagen., 11 (Suppl. 12), 1-158.
34. NCI/NTP. (1978) Carcinogenesis Technical Report Series; National Cancer Institute/National Toxicology Program; US Department of Health and Human Services, TR-46.
35. Hilliard, C. A., Armstrong, M. J., Bradt, C. I., Hill, R. B., Greenwood, S. K. and Galloway, S. M. (1998) Chromosome aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons. Environ. Mol. Mutagen., 31, 316-326. (Pubitemid 28308461)
36. Tucker, J. D., Auletta, A., Cimino, M. C., Dearfield, K. L., Jacobson-Kram, D., Tice, R. R. and Carrano, A. V. (1993) Sister-chromatid exchange: second report of the Gene-Tox Program. Mutat. Res., 297, 101-180. (Pubitemid 23214970)
37. International Agency for Research on Cancer. (1977). IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 13. Some Miscellaneous Pharmaceutical Substances. IARC, Lyon, France, pp. 83-89.
38. International Agency for Research on Cancer. (2001). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 79. Some Thyrotropic Agents, IARC, Lyon, France, pp. 291-315.
39. Kier, L. E., Brusik, D. J., Auletta, A. E. et al. (1986) The Salmonella typhimurium mammalian microsomal assay. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 168, 9-240.
40. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T. and Mortelmans, K. (1992) Salmonella mutagenicity tests. V. Results from the testing of 311 chemicals. Environ. Mol. Mutagen., 18 (Suppl. 21), 2-141.
41. Zimermann, F. K., Von Borstel, R. C., Von Halle, E. S., Parry, J. M., Siebert, D., Zetterberg, G., Barale, R. and Loprieno, N. (1984) Testing of chemicals for genetic activity with Saccharomyces cerevisiae: a report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 133, 199-244. (Pubitemid 14105533)
42. Käfer, E., Scott, B. R., Dorn, G. L. and Stafford, R. (1982) Aspergillus nidulans: systems and results of tests for chemical induction of mitotic segregation and mutation. I. Diploid and duplication assay systems. A report of the U.S. EPA Gene-Tox Program. Mutat. Res., 98, 1-48. (Pubitemid 12163274)
43. Grant, W. F. (1982) Chromosome aberrations assays in Allium. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 99, 273-291.
44. Sofuni, T., Honma, M., Hayashi, M. et al. (1996) Detection of in vitro clastogenic and spindle poisons by the mouse lymphoma assay using the microwell method: interim report of an international collaborative study. Mutagenesis, 11, 349-355. (Pubitemid 26235486)
45. Garriott, M. L., Phelps, J. B. and Hoffman, W. P. (2002) A protocol for the in vitro micronucleus test. I. Contributions to the development of a protocol suitable for regulatory submissions from an examination of 16 chemicals with different mechanisms of action and different levels of activity. Mutat. Res., 517, 123-134. (Pubitemid 34597012)
46. Von der Hude, W., Kalweit, S., Enghelhardt, G. et al. (2000) In vitro micronucleus assay with Chinese hamster V79 cells: results of a collaborative study with in situ exposure to 26 chemical substances. Mutat. Res., 468, 137-163. (Pubitemid 30406853)
47. Muehlbauer, P. A. Q. and Schuler, M. J. (2005) Detection of numerical chromosomal aberrations by flow cytometry: a novel process for identifying aneugenic agents. Mutat. Res., 585, 156-169.
48. Curry, P. T., Reed, R. N., Martini, R. M. and Kitchin, R. M. (1984) Induction of sister-chromatid exchanges in vivo in mice by the mycotoxins sterigmatocystin and griseofulvin. Mutat. Res., 137, 111-115. (Pubitemid 14028709)
49. Wyrobek, A. J., Gordon, L. A., Burkhart, J. G., Francis, M. W., Kapp, R. W., Letz, G., Malling, H. V., Topham, J. C. and Whorton, M. D. (1983) An evaluation of the mouse sperm morphology test and other sperm tests in non human mammals. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 115, 1-72. (Pubitemid 13122041)
50. International Agency for Research on Cancer. (1976). IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 10. Some Naturally Occurring Substances. IARC, Lyon, France, pp. 153-161.
51. Nesnow, S., Argus, M., Bergman, H. et al. (1986) Chemical carcinogens. A review and analysis of the literature of selected chemicals and the establishment of the Gene-Tox Carcinogen Data Base. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 185, 1-195. (Pubitemid 17215638)
52. Braun, R., Jäkel, H.-P. and Schöneich, J. (1984) Genetic effects of isoniazid and the relationship to in vivo and in vitro biotransformation. Mutat. Res., 137, 61-69.
53. Legator, M. S., Bueding, E., Batzinger, R. et al. (1982) An evaluation of the host-mediated assay and body fluid analysis. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 98, 319-374. (Pubitemid 12074502)
54. Russel, L. B., Selby, P. B., Von Halle, E., Sheridan, W. and Valcovic, L. (1981) Use of the mouse spot test in chemical mutagenesis: interpretation of past data and recommendation for future work. Mutat. Res., 86, 355-379. (Pubitemid 11063721)
55. Latt, S. A., Allen, J., Bloom, S. E. et al. (1981) Sister-chromatid exchanges. A report of the Gene-Tox Program. Mutat. Res., 87, 17-62. (Pubitemid 11042443)
56. Green, S., Auletta, A., Fabricant, J., Kapp, R., Marrandhar, M., Sheu, C., Springer, J. and Whitefield, B. (1985) Current status of bioassays in genetic toxicology - the dominant lethal test. A report of the U.S. Environmental Protection Agency Gene-Tox program. Mutat. Res., 154, 49-67. (Pubitemid 15039544)
57. The Carcinogenic Potency Database. http://www.potency.berkley.edu.
58. International Agency for Research on Cancer. (1974). IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 4. Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. IARC, Lyon, France, pp. 159-172.
59. International Agency for Research on Cancer. (1987). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Supplement 7. Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42. Lyon, France: IARC pp. 250-252.
60. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., Mortelmans, K. and Speck, W. (1987) Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ. Mol. Mutagen., 9 (Suppl. 9), 1-110. (Pubitemid 17115119)
61. NCI/NTP (1978) Carcinogenesis Technical Report Series; National Cancer Institute/National Toxicology Program; US Department of Health and Human Services, TR-48.
62. Leifer, Z., Tikada, T., Mandel, M., Zeiger, E., Stafford, R. and Rosenkranz, H. S. (1981) An evaluation of tests using DNA repair-deficient bacteria for predicting genotoxicity and carcinogenicity. A report of the U.S. EPA's Gene-Tox Program. Mutat. Res., 87, 211-297. (Pubitemid 12207743)
63. Haworth, S., Lawlor, T., Mortelmans, K., Speck, W. and Zeiger, E. (1983) Salmonella mutagenicity test results for 250 chemicals. Environ. Mutagen., 5, 3-142. (Pubitemid 14168891)
64. Ryden, E., Ekstrom, C., Hellmer, L. and Bolcsfoldi, G. (2000) Comparison of the sensitivities of Salmonella typhimurium strains TA102 and TA 2638A to 16 mutagens. Mutagenesis, 15, 495-502.
65. De Flora, S., Camoirano, A., Zanacchi, P. and Bennicelli, C. (1984) Mutagenicity testing with Salmonella typhimurium strains TA97 and TA102 of 30 DNA-damaging compounds, negative with other Salmonella strains. Mutat. Res., 134, 159-165. (Pubitemid 15216570)
66. Ma, T.-H. (1982) Vicia cytogenetic tests for environmental mutagens. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 99, 257-271.
67. Short-term test sponsored by the Division of Cancer Biology, National Cancer Institute, U.S., Ms. Ellen Zaika,assistant project officer, 1986.
68. Knasmüller, S., Parzefall, W., Helma, C., Kassie, F., Ecker, S. and Schulte-Hermann, R. (1997) Toxic effects of griseofulvin: disease models, mechanism, and risk assessment. Crit. Rev. Toxicol., 27, 495-537. (Pubitemid 27448569)
69. Wutzler, P. and Thust, R. (2001) Genetic risks of antiviral nucleoside analogues - a survey. Antivir. Res., 49, 55-74. (Pubitemid 32206741)
70. Tennant, R. W., Margolin, B. H. et al. (1987) A comprehensive analysis of data on the clastogenicity genesis in rodents from in vitro genetic toxicity assays. Science, 236, 933-941. (Pubitemid 17107941)
71. Zeiger, E., Haseman, J. K., Shelby, M. D., Margolin, B. H. and Tennant, R. W. (1990) Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen., 16 (Suppl. 18), 1-14. (Pubitemid 20376833)
72. Kirkland, D., Aardema, M., Henderson, L. and Muller, L. (2005) Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutat. Res., 584, 1-256. (Pubitemid 40922793)
73. Kirkland, D. J., Hayashi, M., Jacobson-Kram, D., Kasper, P., MacGregor, J. T., Müller, L. and Uno, Y. (2007) Summary of major conclusions from the 4th IWGT, San Francisco, 9-10 September 2005. Mutat. Res., 627, 5-9. (Pubitemid 46091763)
74. Thybaud, V., Aardema, M., Clements, J. et al. (2007) Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing. Mutat. Res., 627, 41-58. (Pubitemid 46091766)
75. Tweats, D. J., Blakey, D., Heflich, R. H. et al. (2007) Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests. I. Increases in micronucleated bone marrow cells in rodents that do not indicate genotoxic hazards. Mutat. Res., 627, 78-91. (Pubitemid 46098931)
76. Kirkland, D. and Speit, G. (2008) Evaluation of the ability of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. III. Appropriate follow-up testing in vivo. Mutat. Res., 654, 114-132.
77. Brambilla, G. and Martelli, A. (2007) Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products. Mutat. Res., 635, 17-52. (Pubitemid 46482377)